LU91180I2 - 2-(2-Nirto-4trifluoromethylbenzoyl)-1,3-cyclohexanedione ou un de ses sels (en abréviation "NTBC", nom commun nitisinone, nom de marque orfadin. - Google Patents

2-(2-Nirto-4trifluoromethylbenzoyl)-1,3-cyclohexanedione ou un de ses sels (en abréviation "NTBC", nom commun nitisinone, nom de marque orfadin.

Info

Publication number: LU91180I2
Authority: LU; Luxembourg
Prior art keywords: cyclohexanedione; nirto; ntbc; nitisinone; abbreviation
Prior art date: 1991-06-24

Application number

LU91180C

Other languages

English (en)

Original Assignee

Syngenta Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-06-24

Filing date

2005-07-06

Publication date

2005-09-06

1991-06-24 Priority claimed from GB919113622A external-priority patent/GB9113622D0/en

1992-03-24 Priority claimed from GB929206412A external-priority patent/GB9206412D0/en

2005-07-06 Application filed by Syngenta Ltd filed Critical Syngenta Ltd

2005-09-06 Publication of LU91180I2 publication Critical patent/LU91180I2/fr

Links

OUBCNLGXQFSTLU-UHFFFAOYSA-N nitisinone Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1C(=O)CCCC1=O OUBCNLGXQFSTLU-UHFFFAOYSA-N 0.000 title 3
229960001721 nitisinone Drugs 0.000 title 2
229940039219 orfadin Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 abstract 3
102100028626 4-hydroxyphenylpyruvate dioxygenase Human genes 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
QMNFICMPAXFAPC-UHFFFAOYSA-N 2-benzoylcyclohexane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C1C(=O)CCCC1=O QMNFICMPAXFAPC-UHFFFAOYSA-N 0.000 abstract 1
208000032001 Tyrosinemia type 1 Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
230000002503 metabolic effect Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
201000011296 tyrosinemia Diseases 0.000 abstract 1
201000007972 tyrosinemia type I Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Inorganic Compounds Of Heavy Metals (AREA)
Hydrogenated Pyridines (AREA)

LU91180C 1991-06-24 2005-07-06 2-(2-Nirto-4trifluoromethylbenzoyl)-1,3-cyclohexanedione ou un de ses sels (en abréviation "NTBC", nom commun nitisinone, nom de marque orfadin. LU91180I2 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB919113622A GB9113622D0 (en)	1991-06-24	1991-06-24	Medicinal agents
GB929206412A GB9206412D0 (en)	1992-03-24	1992-03-24	Pharmaceutical compositions
PCT/GB1992/001094 WO1993000080A1 (fr)	1991-06-24	1992-06-18	Utilisation de 2-(2-nitro-4-trifluoromethylbenzoyle)-1,3-cyclohexanedione pour le traitement de la tirosinemie et compositions pharmaceutiques

Publications (1)

Publication Number	Publication Date
LU91180I2 true LU91180I2 (fr)	2005-09-06

Family

ID=26299120

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU91180C LU91180I2 (fr)	1991-06-24	2005-07-06	2-(2-Nirto-4trifluoromethylbenzoyl)-1,3-cyclohexanedione ou un de ses sels (en abréviation "NTBC", nom commun nitisinone, nom de marque orfadin.

Country Status (16)

Country	Link
US (1)	US5550165A (fr)
EP (1)	EP0591275B1 (fr)
JP (1)	JP3130935B2 (fr)
AT (1)	ATE178207T1 (fr)
AU (1)	AU672361B2 (fr)
CA (1)	CA2072047C (fr)
DE (2)	DE69228813T2 (fr)
DK (1)	DK0591275T3 (fr)
ES (1)	ES2129448T3 (fr)
GR (1)	GR3029841T3 (fr)
IE (1)	IE922024A1 (fr)
LU (1)	LU91180I2 (fr)
NL (1)	NL300198I2 (fr)
NO (3)	NO304923B1 (fr)
PT (1)	PT100619B (fr)
WO (1)	WO1993000080A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4305696A1 (de) *	1993-02-25	1994-09-01	Hoechst Ag	Nachweisverfahren zur Identifizierung von Inhibitoren
AU5116099A (en) *	1998-07-21	2000-02-14	Sui Xiong Cai	Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof
GB0504103D0 (en) *	2005-02-28	2005-04-06	Syngenta Ltd	Novel method
CA2659424A1 (fr) *	2006-08-18	2008-02-21	Syngenta Limited	Utilisation d'inhibiteurs de l'hppd dans le traitement de la depression et/ou des symptomes de sevrage associes aux drogues engendrant la dependance
JP5867081B2 (ja) *	2010-01-29	2016-02-24	東レ株式会社	胆道疾患の治療又は予防剤
RS54632B1 (sr) *	2011-06-23	2016-08-31	Swedish Orphan Biovitrum International Ab	Tečna farmaceutska kompozicija koja sadrži nitizinon
WO2013181292A1 (fr) *	2012-05-29	2013-12-05	Biotie Therapies, Inc.	Formulations de nitisinone
CN102976948B (zh) *	2012-11-28	2014-07-09	郑州大明药物科技有限公司	尼替西农的制备方法
GB201400117D0 (en)	2014-01-03	2014-02-19	Cycle Pharmaceuticals Ltd	Pharmaceutical composition
ITUB20160650A1 (it) *	2016-02-11	2017-08-11	Dipharma S A	Formulazioni farmaceutiche solide stabili contenenti 2-(2-nitro-4-trifluorometilbenzoil)-1,3-cicloesandione
US9783485B1 (en)	2016-11-30	2017-10-10	Dipharma S.A.	Crystalline inhibitor of 4-hydroxyphenylpyruvate dioxygenase, and a process of synthesis and crystallization thereof
EP3888684A1 (fr) *	2020-03-31	2021-10-06	Bayer Animal Health GmbH	Composition ayant une acceptation volontaire améliorée
CN112460914A (zh) *	2020-11-01	2021-03-09	江苏珠合新能源科技有限公司	一种干冰机尾气冷量回收调节工艺装置
WO2024047657A1 (fr) *	2022-08-28	2024-03-07	Brawn Laboratories Ltd	Procédé de préeparation de nitisinone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4780127A (en) *	1982-03-25	1988-10-25	Stauffer Chemical Company	Certain 2-(substituted benzoyl)-1,3-cyclohexanediones and their use as herbicides
IL77349A (en) *	1984-12-20	1990-07-12	Stauffer Chemical Co	2-(2'-nitrobenzoyl)-1,3-cyclohexanediones,their preparation and their use as herbicides
US4774360A (en)	1987-06-29	1988-09-27	Stauffer Chemical Company	Converting enol ester precursor of a benzoyl-1,3-cycloalkyldione to a benzoyl-1,3-cycloalkyldione
US4859234A (en)	1987-09-14	1989-08-22	Ici Americas Inc.	Herbicidal compositions of acylated 1,3-dicarbonyl herbicides and phenoxyalkanoic acids, salts, amides and esters therof as antidotes

1992
- 1992-06-18 AU AU19860/92A patent/AU672361B2/en not_active Expired
- 1992-06-18 DE DE69228813T patent/DE69228813T2/de not_active Expired - Lifetime
- 1992-06-18 WO PCT/GB1992/001094 patent/WO1993000080A1/fr not_active Ceased
- 1992-06-18 JP JP05501383A patent/JP3130935B2/ja not_active Expired - Lifetime
- 1992-06-18 EP EP92912215A patent/EP0591275B1/fr not_active Expired - Lifetime
- 1992-06-18 ES ES92912215T patent/ES2129448T3/es not_active Expired - Lifetime
- 1992-06-18 DE DE1992628813 patent/DE122005000032I2/de active Active
- 1992-06-18 AT AT92912215T patent/ATE178207T1/de active
- 1992-06-18 DK DK92912215T patent/DK0591275T3/da active
- 1992-06-23 CA CA002072047A patent/CA2072047C/fr not_active Expired - Lifetime
- 1992-06-24 PT PT100619A patent/PT100619B/pt not_active IP Right Cessation
- 1992-07-01 IE IE202492A patent/IE922024A1/en not_active IP Right Cessation
1993
- 1993-12-23 NO NO934798A patent/NO304923B1/no active Protection Beyond IP Right Term
1994
- 1994-12-19 US US08/359,361 patent/US5550165A/en not_active Expired - Lifetime
1999
- 1999-04-01 GR GR990400803T patent/GR3029841T3/el unknown
2005
- 2005-06-09 NL NL300198C patent/NL300198I2/nl unknown
- 2005-07-06 LU LU91180C patent/LU91180I2/fr unknown
- 2005-08-31 NO NO2005018C patent/NO2005018I2/no unknown
2017
- 2017-08-23 NO NO2017045C patent/NO2017045I1/no unknown

Also Published As

Publication number	Publication date
NL300198I2 (nl)	2005-09-01
DE69228813T2 (de)	1999-08-05
NO304923B1 (no)	1999-03-08
US5550165A (en)	1996-08-27
EP0591275B1 (fr)	1999-03-31
CA2072047A1 (fr)	1992-12-25
DE122005000032I2 (de)	2006-06-08
AU1986092A (en)	1993-01-25
NL300198I1 (nl)	2005-08-01
NO2017045I1 (no)	2017-08-23
JP3130935B2 (ja)	2001-01-31
AU672361B2 (en)	1996-10-03
NO2005018I1 (no)	2005-09-26
NO934798D0 (no)	1993-12-23
NO2005018I2 (no)	2008-02-11
ATE178207T1 (de)	1999-04-15
DE69228813D1 (de)	1999-05-06
PT100619B (pt)	1999-07-30
JPH06508628A (ja)	1994-09-29
DK0591275T3 (da)	1999-10-11
IE922024A1 (en)	1992-12-30
HK1008662A1 (en)	1999-05-14
WO1993000080A1 (fr)	1993-01-07
PT100619A (pt)	1994-01-31
EP0591275A1 (fr)	1994-04-13
ES2129448T3 (es)	1999-06-16
GR3029841T3 (en)	1999-07-30
DE122005000032I1 (de)	2005-09-29
NO934798L (no)	1993-12-23
CA2072047C (fr)	2003-06-10

Similar Documents

Publication	Publication Date	Title
NO2017045I1 (no)	2017-08-23	Farmasøøytisk preparat inneholdende 2-(2-nitro-4-ifluormetylbenzoyl)-1,3-cykloheksandion eller et farmasøytisk godtagbart salt derav
US5453276A (en)	1995-09-26	Antimicrobial compositions of indole and naturally occurring antimicrobials
EP0252278A3 (fr)	1990-09-12	Agents désinfectants et leur utilisation pour la désinfection de la peau et des membranes muqueuses
BR9712070A (pt)	2002-01-15	Composição aquosa anticorrosiva desinfetante e esterelizante e processos de formação da mesma, e, de desinfecção de uma superfìcie
AR019876A1 (es)	2002-03-20	Uso de una solucion liquida desinfectante que contiene un compuesto antimicrobiano para la desinfeccion composicion desinfectante que lo contiene
KR950031059A (ko)	1995-12-18	골다공증 치료용 약제학적 조성물
BR0107157A (pt)	2002-07-16	Diagnose e tratamento de condições cardiovasculares
ES2163472T3 (es)	2002-02-01	Caseinas micelarias fluoradas.
BR0009280A (pt)	2001-12-26	Composições antimicrobianas para limpeza dedentaduras
ES2087623T3 (es)	1996-07-16	Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
BR0113461A (pt)	2003-07-01	Compostos ou sais farmaceuticamente aceitáveis, composições farmacêuticas, método de tratamento de doença ou condição mediada por erab, hadh2 ou (beta)-amilóide em mamìferos, métodos de inibição ou modulação da atividade enzimática de erab ou hadh2 e método de tratamento de mal de alzheimer ou demência em mamìferos
HN1997000070A (es)	1997-09-08	Inhibición de las metaloproteinasas de matriz por acidos 2-((1)-aroilalquil) -4-biaril-4-oxoburiticos
Jaeschke et al.	1986	Manipulation of mouse organ glutathione contents II: Time and dose-dependent induction of the glutathione conjugation system by phenolic antioxidants
BR9713122A (pt)	2000-04-11	Composição inseticida e miticida e processo para preparação da mesma
BR9712926A (pt)	1999-12-07	Sabão anti-séptico em barra
BR9808054A (pt)	2000-11-07	Método de tratamento e/ou prevenção de diabete melito não-dependente de insulina e composição
GB9126874D0 (en)	1992-02-19	Medicaments
ES2122005T3 (es)	1998-12-16	Medicamento que contiene (-)-metrifonato.
KR960000240A (ko)	1996-01-25	치주질환 예방 및 치료제 조성물
KR960703512A (ko)	1996-08-31	농업용/원예용 살균제 조성물(Germicidal Composition for Agiricultural/Horticultural Use)
ATE190316T1 (de)	2000-03-15	Peptid-aldehydderivate als antikoagulierende mittel
ES2151710T3 (es)	2001-01-01	Soportes impregnados con una composicion desinfectante.
KR970032884A (ko)	1997-07-22	가축질병의 치료 및 예방을 위한 면역증강제
KR950016765A (ko)	1995-07-20	알로인, 알로에-애모딘 및 알로에-에모딘 안트론을 유효성분으로 하는 알콜성 간장질환 예방 치료제 조성물
Gaster	1944	The Furniture of El in Canaanite Mythology